China 115619-01-7 Factory

Well-run gear, qualified revenue workforce, and superior after-sales companies; We've been also a unified huge loved ones, anyone persist with the organization benefit "unification, determination, tolerance" for 115619-01-7,CAS NO 115619-01-7,Infigratinib intermediate,Infigratinib advance intermediate,4-(4-Ethylpiperazin-1-ly)aniline, We fully welcome shoppers from all around the world to ascertain stable and mutually effective enterprise interactions, to have a dazzling long run jointly.
115619-01-7, We hope to have long-term cooperation relationships with our clients. If you are interested in any of our items, be sure to do not hesitate to send enquiry to us/company name. We ensure that you can be totally satisfied with our best solutions!

Hot Products

  • Pioglitazone hydrochloride

    Pioglitazone hydrochloride

    Product Name:Pioglitazone hydrochloride
    Molecular Formula:C19H21ClN2O3S
    Molecular Weight;392.9
    CAS Registry Number;112529-15-4
  • N-Tosyl-5-bromo-4,7-diazaindole

    N-Tosyl-5-bromo-4,7-diazaindole

    Product Name:N-Tosyl-5-bromo-4,7-diazaindole
    Molecular Formula:C13H10BrN3O2S
    Molecular Weight:352.21
    CAS Registry Number:1201186-54-0
  • Azelaic acid

    Azelaic acid

    Product Name:Azelaic acid
    Molecular Formula:C9H16O4
    Molecular Weight;188.22
    CAS Registry Number;123-99-9
  • Benzyltriethylammonium chloride

    Benzyltriethylammonium chloride

    Product Name:Benzyltriethylammonium chloride
    Molecular Formula:C13H22ClN
    Molecular Weight:227.77
    CAS Registry Number:56-37-1
  • Salbutamol

    Salbutamol

    Product Name:Salbutamol
    Molecular Formula:C13H21NO3
    Molecular Weight;239.31
    CAS Registry Number;34391-04-3
  • 2,5-Difluorotoluene

    2,5-Difluorotoluene

    Product Name:2,5-Difluorotoluene
    Molecular Formula:C7H6F2
    Molecular Weight:128.12
    CAS Registry Number:452-67-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept